Publications by authors named "Kendall B Knuth"
Article Synopsis
- This exploratory study examines the differences in self-reported COVID-19 vaccine side effects and breakthrough infections between individuals with diabetes and those without diabetes.
- The research was conducted using data from adult participants in the U.S. who voluntarily provided information about their health, vaccinations, and any side effects experienced.
- Results indicated that individuals with diabetes reported fewer side effects after vaccination compared to those without diabetes, highlighting potential differences in vaccine reactions based on diabetic status.
Objective: To describe cognitive symptoms in people not hospitalised at study enrolment for SARS-CoV-2 infection and associated demographics, medical history, other neuropsychiatric symptoms and SARS-CoV-2 vaccination.
Design: Longitudinal observational study.
Setting: Direct-to-participant registry with community-based recruitment via email and social media including Google, Facebook and Reddit, targeting adult US residents.
Article Synopsis
- COVID-19 has underscored the necessity for improved pharmacovigilance methods, leading to a study using community volunteers to track vaccine effectiveness and the characteristics of breakthrough infections.
- Between December 2020 and September 2021, over 11,800 volunteers provided data on their vaccination status and COVID-19 symptoms, revealing that fully vaccinated individuals had a lower incidence of infection compared to partially vaccinated and unvaccinated groups.
- The findings indicated that most breakthrough infections in fully vaccinated individuals were asymptomatic or mild, and the study supports the value of patient-reported data in assessing vaccine impact and infection severity.
Excessive drinking, including binge and heavy drinking, is a leading cause of morbidity and mortality in North Carolina. In 2010, excessive drinking cost North Carolina $7.03 billion, and this analysis aimed to update this figure for 2017.
View Article and Find Full Text PDFIn August 2019, the North Carolina Division of Public Health (NCDPH) began investigating e-cigarette, or vaping, product use-associated lung injury (EVALI) cases as part of a national response. We describe clinical, epidemiologic, and laboratory findings of North Carolina EVALI patients. NCDPH requested that physicians report cases of respiratory illness or bilateral pulmonary infiltrates or opacities in patients who reported using e-cigarette, or vaping, products and had no infection or alternative plausible diagnoses.
View Article and Find Full Text PDF